GlassScriptPhysician profile
Joshua Lisonbee
NPI 1902331705
$1,916.31
in general payments reported to CMS, 2019-2025
11 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $430 · 2021: $85.61 · 2022: $919 · 2023: $46.59 · 2024: $216 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,234.29 | 2020-2025 | Prostep |
| Zimmer Biomet Holdings, INC. | $205.09 | 2020 | |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Organogenesis INC. | $84.52 | 2021-2023 | Puraply |
| Treace Medical Concepts, INC. | $79.53 | 2024-2025 | |
| Smith+Nephew, INC. | $51.66 | 2022-2025 | Grafix, Collagenase Santyl |
| Nevro Corp. | $22.88 | 2023 | Senza |
| Paratek Pharmaceuticals, INC. | $18.94 | 2025 | Nuzyra |
| Paragon 28, INC. | $17.35 | 2022 | |
| Medtronic, INC. | $17.23 | 2021 | |
| Orthofix Medical, INC. | $7.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Lisonbee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.